Masterbatches and compounds utilizing the mevopur colorants will minimize drug adulteration caused by leaching of substances from the plastics packaging, the company said. Clariant global segment medical & pharmaceutical head steve duckworth said within the pharmaceutical packaging sector there has been increased awareness of extractables and leachables from plastics and how changes in the materials may often result in unintended contamination of medicine. &ldquoby offering a preevaluated range of colorants, we give our customers the confidence and ability to explore exciting new colour options for their packaging, knowing that the risks and the costs of a failure in late stage development or productlife cycle are reduced,&rdquo duckworth added.
The colorants are manufactured at the company&rsquos three dedicated medical and pharmaceutical centres of competence in the us, europe and asia respectively.
